Open AccessAtypical femur fracture incidence in women increases with duration of bisphosphonate exposure
Author(s) -
Joan C. Lo,
Christopher D. Grimsrud,
Susan M. Ott,
Malini Chandra,
Rita L. Hui,
Bruce Ettinger
Publication year - 2019
Publication title -
osteoporosis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 170
eISSN - 1433-2965
pISSN - 0937-941X
DOI - 10.1007/s00198-019-05112-5
Subject(s) - medicine , incidence (geometry) , population , osteoporosis , hip fracture , femur , bisphosphonate , femur fracture , surgery , pediatrics , environmental health , physics , optics
In a northern California population of older women who were treated with oral bisphosphonate drugs, the incidence of atypical femur fracture, a rare complication of treatment, increased with longer duration of bisphosphonate exposure. These findings align with those previously reported in an independent southern California population.